[EN] NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS<br/>[FR] ANALOGUES D'ARIADNE NON HALLUCINOGÈNES POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES ET PSYCHIATRIQUES
申请人:[en]THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
公开号:WO2022204323A1
公开(公告)日:2022-09-29
The present invention provides a compound having the structure (I) wherein R1is (C2-C12alkyl), - (alkenyl), - (alkynyl), - (cycloalkyl); R2is H, halogen, -NO2, -CN, -CF3, -CF2H, -CH2OCH3, -CF2CH3, CF2OCH3, (alkyl), - (alkenyl), - (alkynyl), - (cycloalkyl), (cycloalkylalkyl), - (heteroalkyl), - (heterocycle), (heterocycloalkyl), - (aryl), - (heteroaryl), - (hydroxyalkyl), (haloalkyl), - (alkylaryl), -OH, -O- (alkyl), -O- (alkenyl), -O- (alkynyl), -O- (haloalkyl), -O- (aryl), -O- (heteroaryl), -OCF3, SH, -S- (alkyl), -S- (alkenyl), -S- (alkynyl), -S- (aryl), -S- (heteroaryl), -NH2, -NH- (alkyl), -NH- (alkenyl), -NH- (alkynyl), -N- (alkyl)2, NH- (aryl), -NH- (heteroaryl), -CO2H, -CO2- (alkyl ), C (O) -NH2, -C (O) -NH- (alkyl), -C (O) -NH- (aryl), -SO2CH3or Si (CH3)3; R3is -OCH3, -OCH2CH3, -F or -Cl; and R4is -OCH3, -OCH2CH3or -SCH3; wherein when R1is -CH2CH3, R3is -OCH3, and R4is -OCH3, then R2is other than H, -CH3, -CH2CH3, -CH2CH2CH3, -CH(CH3)2, CH2CH2CH2CH3, -CH2OH, -CH (OH) CH3, -OH, -OCH2CH3, -OCH2CH2CH3, OCH (CH3)2, -SCH3, -SCH2CH3, -SCH2CH2CH3, -NO2, -NH2, -F, -Cl, -Br or - 1, or a pharmaceutically acceptable salt thereof.